RBC Europe’s Bristol-Myers Squibb BMY Stock Holding History

RBC Europe’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$1.06M	Sell	13,767 -2,030	-13%	-$155K	0.05%	108
2022 Q1	$1.15M	Sell	15,797 -144	-0.9%	-$9.67K	0.05%	103
2021 Q4	$994K	Sell	15,941 -7,335	-32%	-$430K	0.04%	110
2021 Q3	$1.38M	Hold	23,276	–	–	0.06%	123
2021 Q2	$1.56M	Sell	23,276 -300	-1%	-$19.6K	0.07%	119
2021 Q1	$1.49M	Sell	23,576 -1,611	-6%	-$100K	0.08%	116
2020 Q4	$1.56M	Sell	25,187 -100	-0.4%	-$6.15K	0.09%	110
2020 Q3	$1.52M	Sell	25,287 -200	-0.8%	-$12K	0.1%	103
2020 Q2	$1.5M	Buy	25,487 +7,625	+43%	+$456K	0.12%	94
2020 Q1	$996K	Sell	17,862 -221	-1%	-$13.5K	0.1%	102
2019 Q4	$1.16M	Buy	18,083 +2,864	+19%	+$164K	0.1%	109
2019 Q3	$772K	Buy	15,219 +260	+2%	+$12.2K	0.08%	128
2019 Q2	$678K	Sell	14,959 -2,842	-16%	-$132K	0.07%	138
2019 Q1	$849K	Sell	17,801 -803	-4%	-$40K	0.09%	123
2018 Q4	$967K	Sell	18,604 -6,305	-25%	-$339K	0.13%	104
2018 Q3	$1.55M	Sell	24,909 -990	-4%	-$58.8K	0.17%	94
2018 Q2	$1.43M	Sell	25,899 -2,366	-8%	-$128K	0.17%	94
2018 Q1	$1.79M	Buy	28,265 +1,610	+6%	+$104K	0.22%	85
2017 Q4	$1.63M	Sell	26,655 -190	-0.7%	-$11.9K	0.2%	92
2017 Q3	$1.71M	Buy	+26,845	New	+$1.57M	0.22%	88

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

RBC Europe's BMY Position: Q2 2022 in Review

RBC Europe reduced its Bristol-Myers Squibb (BMY) stake by 13% in Q2 2022, selling an estimated $155K and leaving 13,767 shares worth $1.06M. The position accounts for 0.05% of the portfolio, ranked #108.

RBC Europe first reported a position in BMY in Q3 2017 and has held it in 20 quarters since. The position peaked at $1.79M in Q1 2018. 2,538 funds tracked by Wall St. Rank hold BMY as of Q2 2022.

RBC Europe held 13,767 shares of Bristol-Myers Squibb worth $1.06M as of Q2 2022.
RBC Europe sold 2,030 Bristol-Myers Squibb shares in Q2 2022, an estimated $155K.
Bristol-Myers Squibb made up 0.05% of RBC Europe's portfolio in Q2 2022, its #108 holding.
RBC Europe first reported a position in Bristol-Myers Squibb in Q3 2017 and has held it in 20 quarters since.
RBC Europe's Bristol-Myers Squibb position peaked at $1.79M in Q1 2018.
2,538 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2022.

Based on RBC Europe's 13F filing for Q2 2022, filed 14 Nov 2022.